← Back to search

HypaHub

A Cloud-Based Bioinformatics and AI Platform

Y CombinatorWinter 2022AcquiredB2BAnalyticsMachine LearningBiotechAnalytics

What they do

Problem

Organizations and scientists struggle to deploy, manage, and afford compliant bioinformatics and AI compute infrastructure for data analytics and application development.

Solution

HypaHub provides a HIPAA-compliant bioinformatics and AI SaaS platform that runs natively on customers' clouds and automates provisioning and operation of computing resources.

Who it's for

Scientists and enterprise teams in healthcare and life sciences building data applications or performing bioinformatics analytics on cloud data.

Founders

Hugo Lam
Founder

Hugo has over 20 years of experience in software, bioinformatics, and genomics, including time at Roche (SW: ROG), Bina (acquired by Roche), Personalis (NASDAQ: PSNL), 23andMe (NASDAQ: ME), and PCCW (SEHK: 8). Prior to founding HypaHub, Hugo was Senior Director and Head of Bioinformatics at Roche. He is an alumnus of HKUST, Imperial College London, Yale University, Stanford Medical School, and Cambridge Judge Business School. He has published in over 40 publications with over 35,000 citations.

Company timeline

Similar startups